| NCT Number | NCT07511062 |
| Lead Sponsor | Northside Hospital, Inc.
Collaborators: Incyte Corporation |
| Conditions | Acute Myeloid Leukemia, TP53 Gene Mutation |
| Enrollment | 32 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2029-08-01 (estimated) |
| Study Completion | 2030-08-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-06 |